| Allgood, P. C., Duffy, S. W., Kearins, O., O'Sullivan, E., Tappenden, N., Wallis, M. G., & Lawrence, G. Explaining the difference in prognosis between screen-detected and symptomatic breast cancers, British Journal of Cancer, vol. 104, no. 11, pp. 1680-1685. |
| Almonte, M., Sasieni, P., & Cuzick, J. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines, Best.Pract.Res.Clin.Obstet.Gynaecol., vol. 25, no. 5, pp. 617-629. |
| Baldwin, D. R., Duffy, S. W., Wald, N. J., Page, R., Hansell, D. M., & Field, J. K. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer, Thorax, vol. 66, no. 4, pp. 308-313. |
| Bissett, S. L., Howell-Jones, R., Swift, C., De Silva, N., Biscornet, L., Parry, J. V., Saunders, N. A., Nathan, M., Soldan, K., Szarewski, A., Cuzick, J., & Beddows, S. Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males, J.Med.Virol., vol. 83, no. 10, pp. 1744-1751. |
| Clark, S. E., Warwick, J., Carpenter, R., Bowen, R. L., Duffy, S. W., & Jones, J. L. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease, British Journal of Cancer, vol. 104, no. 1, pp. 120-127. |
| Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & Forbes, J. F. 10-year analysis of the ATAC trial: wrong conclusion? Reply, Lancet Oncology, vol. 12, no. 3, p. 217. |
| Cuzick, J., Swanson, G. P., Fisher, G., Brothman, A. R., Berney, D. M., Reid, J. E., Mesher, D., Speights, V. O., Stankiewicz, E., Foster, C. S., Moller, H., Scardino, P., Warren, J. D., Park, J., Younus, A., Flake, D. D., Wagner, S., Gutin, A., Lanchbury, J. S., & Stone, S. Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study, Lancet Oncology, vol. 12, no. 3, pp. 245-255. |
| Cuzick, J., Sestak, I., Pinder, S. E., Ellis, I. O., Forsyth, S., Bundred, N. J., Forbes, J. F., Bishop, H., Fentiman, I. S., & George, W. D. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial, Lancet Oncology, vol. 12, no. 1, pp. 21-29. |
| Cuzick, J., Warwick, J., Pinney, E., Duffy, S. W., Cawthorn, S., Howell, A., Forbes, J. F., & Warren, R. M. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study, J.Natl.Cancer Inst., vol. 103, no. 9, pp. 744-752. |
| Cuzick, J., DeCensi, A., Arun, B., Brown, P. H., Castiglione, M., Dunn, B., Forbes, J. F., Glaus, A., Howell, A., von Minckwitz, G., Vogel, V., & Zwierzina, H. Preventive therapy for breast cancer: a consensus statement, Lancet Oncol., vol. 12, no. 5, pp. 496-503. |
| Cuzick, J., Glasier, A., La Vecchia, C., Maraganore, D. M., Negri, E., Rossi, M., Spector, T., Trichopoulos, D., van Baak, M. A., Zocchetti, C., Baird, D. T., Benagiano, G., Collins, J., Crosignani, P. G., Diczfalusy, E., Evers, J. L. H., Gianaroli, L., & Volpe, A. Perimenopausal risk factors and future health, Human Reproduction Update, vol. 17, no. 5, pp. 706-717. |
| Dowsett, M., Salter, J., Zabaglo, L., Mallon, E., Howell, A., Buzdar, A. U., Forbes, J., Pineda, S., & Cuzick, J. Predictive algorithms for adjuvant therapy: TransATAC, Steroids, vol. 76, no. 8, pp. 777-780. |
| Duffy, S. W. & Mackay, J. Elementary flaws in the FH01 study Reply, Lancet Oncology, vol. 12, no. 3, pp. 215-216. |
| Duffy, S. W. & Treasure, F. P. Potential surrogate endpoints in cancer research - some considerations and examples, Pharmaceutical Statistics, vol. 10, no. 1, pp. 34-39. |
| Eastell, R., Adams, J., Clack, G., Howell, A., Cuzick, J., Mackey, J., Beckmann, M. W., & Coleman, R. E. Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial, Ann.Oncol., vol. 22, no. 4, pp. 857-862. |
| Field, J. K., Raji, O. Y., Cassidy, A., Mimnagh, C., Hughes, J., Warburton, C., Giles, T., Liloglou, T., Gosney, J., Calverley, P., Duffy, S. W., Page, R., & Ashton, M. A Pilot Lung Cancer Early Detection Study in A Primary Care Practice in Knowsley, Merseyside: the Liverpool Lung Project Primary Care Implementation Programme (Llp-Pcip), Journal of Thoracic Oncology, vol. 6, no. 6, p. S1393. |
| Field, J. K., Baldwin, D., Brain, K., Devaraj, A., Eisen, T., Duffy, S. W., Hansell, D. M., Kerr, K., Page, R., Parmar, M., Weller, D., Williamson, P., & Whynes, D. CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report, Thorax, vol. 66, no. 8, pp. 736-737. |
| Field, J. K., Duffy, S., Baldwin, D., Brain, K., Eisen, T., Hands, C. J. D., Kerr, K. M., Page, R., Parmar, M., Wald, N., Weller, D., Whynes, D., Williamson, P., & Hansell, D. United Kingdom Lung Cancer Screening (Ukls) Trial, Journal of Thoracic Oncology, vol. 6, no. 6, p. S1382-S1383. |
| Flores, Y. N., Bishai, D. M., Lorincz, A., Shah, K. V., Lazcano-Ponce, E., Hernandez, M., Granados-Garcia, V., Perez, R., & Salmeron, J. HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico, Cancer Causes Control, vol. 22, no. 2, pp. 261-272. |
| Franceschi, S., Denny, L., Irwin, K. L., Jeronimo, J., Lopalco, P. L., Monsonego, J., Peto, J., Ronco, G., Sasieni, P., & Wheeler, C. M. EUROGIN 2010 roadmap on cervical cancer prevention, International Journal of Cancer, vol. 128, no. 12, pp. 2765-2774. |
| Harvie, M. N., Pegington, M., Mattson, M. P., Frystyk, J., Dillon, B., Evans, G., Cuzick, J., Jebb, S. A., Martin, B., Cutler, R. G., Son, T. G., Maudsley, S., Carlson, O. D., Egan, J. M., Flyvbjerg, A., & Howell, A. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women, Int.J.Obes.(Lond), vol. 35, no. 5, pp. 714-727. |
| Hellquist, B. N., Duffy, S. W., Abdsaleh, S., Bjorneld, L., Bordas, P., Tabar, L., Vitak, B., Zackrisson, S., Nystrom, L., & Jonsson, H. Effectiveness of Population-Based Service Screening With Mammography for Women Ages 40 to 49 Years Evaluation of the Swedish Mammography Screening in Young Women (SCRY) Cohort, Cancer, vol. 117, no. 4, pp. 714-722. |
| Jeetle, S., Yang, Z. H., Stankiewicz, E., Fisher, G., Cuzick, J., & Berney, D. Long-term outcome and neuroendocrine differentiation in conservatively treated prostate cancers, Virchows Archiv, vol. 459, p. S59. |
| Kopans, D. B., Smith, R. A., & Duffy, S. W. Mammographic Screening and "Overdiagnosis", Radiology, vol. 260, no. 3, pp. 616-620. |
| Nagtegaal, I. D., Allgood, P. C., Duffy, S. W., Kearins, O., Sullivan, E. O., Tappenden, N., Wallis, M., & Lawrence, G. Prognosis and Pathology of Screen-Detected Carcinomas How Different Are They?, Cancer, vol. 117, no. 7, pp. 1360-1368. |
| O'Brien, M. F., Cronin, A. M., Fearn, P. A., Savage, C. J., Smith, B., Stasi, J., Scardino, P. T., Fisher, G., Cuzick, J., Moller, H., Oliver, R. T., Berney, D. M., Foster, C. S., Eastham, J. A., Vickers, A. J., & Lilja, H. Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively, International Journal of Cancer, vol. 128, no. 10, pp. 2373-2381. |
| Pashayan, N., Pharoah, P., Tabar, L., Neal, D. E., Martin, R. M., Donovan, J., Hamdy, F., & Duffy, S. W. Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence, Cancer Epidemiology, vol. 35, no. 2, pp. 139-144. |
| Pashayan, N., Duffy, S. W., Chowdhury, S., Dent, T., Burton, H., Neal, D. E., Easton, D. F., Eeles, R., & Pharoah, P. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening, British Journal of Cancer, vol. 104, no. 10, pp. 1656-1663. |
| Pashayan, N., Pharoah, P., Neal, D. E., Hamdy, F., Donovan, J., Martin, R. M., Greenberg, D., & Duffy, S. W. PSA-detected prostate cancer and the potential for dedifferentiation-estimating the proportion capable of progression, International Journal of Cancer, vol. 128, no. 6, pp. 1462-1470. |
| Perry, N. M., Patani, N., Milner, S. E., Pinker, K., Mokbel, K., Allgood, P. C., & Duffy, S. W. The impact of digital mammography on screening a young cohort of women for breast cancer in an urban specialist breast unit, European Radiology, vol. 21, no. 4, pp. 676-682. |
| Rajab, R., Fisher, G., Kattan, M. W., Foster, C. S., Moller, H., Oliver, T., Reuter, V., Scardino, P. T., Cuzick, J., & Berney, D. M. An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent, Modern Pathology, vol. 24, no. 1, pp. 58-63. |
| Rajab, R., Fisher, G., Kattan, M. W., Foster, C. S., Moller, H., Oliver, T., Reuter, V., Scardino, P. T., Cuzick, J., & Berney, D. M. An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent, Mod.Pathol., vol. 24, no. 1, pp. 58-63. |
| Sangwa-Lugoma, G., Ramanakumar, A. V., Mahmud, S., Liaras, J., Kayembe, P. K., Tozin, R. R., Lorincz, A., & Franco, E. L. Prevalence and Determinants of High-Risk Human Papillomavirus Infection in Women From a Sub-Saharan African Community, Sexually Transmitted Diseases, vol. 38, no. 4, pp. 308-315. |
| Sasieni, P. D., Shelton, J., Ormiston-Smith, N., Thomson, C. S., & Silcocks, P. B. What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries, British Journal of Cancer, vol. 105, no. 3, pp. 460-465. |
| Schiffman, M., Glass, A. G., Wentzensen, N., Rush, B. B., Castle, P. E., Scott, D. R., Buckland, J., Sherman, M. E., Rydzak, G., Kirk, P., Lorincz, A. T., Wacholder, S., & Burk, R. D. A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study, Cancer Epidemiol.Biomarkers Prev., vol. 20, no. 7, pp. 1398-1409. |
| Singh, S., Cuzick, J., Blake, G. M., Mesher, D., Patel, R., Truscott, J., Coleman, R., Howell, A., Forbes, J., & Eastell, R. One year effect of anastrozole and risedronate on bone mineral density: First results from the IBIS-II bone sub-study, Bone, vol. 48, no. 1, p. S24. |
| Stankiewicz, E., Mesher, D., Ng, M., Cuzick, J., Prowse, D., Hiscock, F., Lu, Y. J., Lam, W., Watkin, N., Corbishley, C., & Berney, D. M. Alternative pathways of Akt Pathway Activation in HPV positive and negative penile carcinomas, Modern Pathology, vol. 24, pp. 225A-226A. |
| Stankiewicz, E., Prowse, D. M., Ktori, E., Cuzick, J., Ambroisine, L., Zhang, X. X., Kudahetti, S., Watkin, N., Corbishley, C., & Berney, D. M. The retinoblastoma protein/p16INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma, Histopathology, vol. 58, no. 3, pp. 433-439. |
| Stankiewicz, E., Mesher, D., Watkin, N., Corbishley, C., Lam, W., & Berney, D. M. Ki67 expression in penile squamous cell carcinoma, Bju International, vol. 108, p. 32. |
| Stankiewicz, E., Mesher, D., Ng, M., Cuzick, J., Prowse, D., Hiscock, F., Lu, F. J., Lam, W., Watkin, N., Corbishley, C., & Berney, D. M. Alternative Pathways of Akt Pathway Activation in HPV Positive and Negative Penile Carcinomas, Laboratory Investigation, vol. 91, pp. 225A-226A. |
| Szarewski, A., Cadman, L., Mesher, D., Austin, J., Ashdown-Barr, L., Edwards, R., Lyons, D., Walker, J., Christison, J., Frater, A., & Waller, J. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial, Br.J.Cancer, vol. 104, no. 6, pp. 915-920. |
| Szarewski, A. & Mansour, D. Study subject to unmeasured confounders and biases, BMJ, vol. 342, p. d3349. |
| Szarewski, A. Ushering in a new era: human papillomavirus (HPV) testing comes to the NHS Cervical Screening Programme, J.Fam.Plann.Reprod.Health Care, vol. 37, no. 2, pp. 64-67. |
| Szarewski, A. Social and psychological aspects of cervical screening, <[11] Journal Name>, vol. 6, no. 1, 37-44. |
| Tabar, L., Vitak, B., Chen, T. H. H., Yen, A. M. F., Cohen, A., Tot, T., Chiu, S. Y. H., Chen, S. L. S., Fann, J. C. Y., Rosell, J., Fohlin, H., Smith, R. A., & Duffy, S. W. Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades, Radiology, vol. 260, no. 3, pp. 658-663. |
| Vasiljevic, N., Wu, K., Brentnall, A. R., Kim, D. C., Thorat, M. A., Kudahetti, S. C., Mao, X., Xue, L., Yu, Y., Shaw, G. L., Beltran, L., Lu, Y. J., Berney, D. M., Cuzick, J., & Lorincz, A. T. Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing, Dis.Markers, vol. 30, no. 4, pp. 151-161. |
| Waller, J., Szarewski, A., Ashdown-Barr, L., & Cadman, L. Barriers to cervical cancer screening among women who have been abused: An exploratory study, Annals of Behavioral Medicine, vol. 41, p. S7. |
| Wong, C. S., Lim, G. H., Gao, F., Jakes, R. W., Offman, J., Chia, K. S., & Duffy, S. W. Mammographic density and its interaction with other breast cancer risk factors in an Asian population, British Journal of Cancer, vol. 104, no. 5, pp. 871-874. |
|
